TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Human Recombinant Erythropoietin (HrEPO) in Asphyxia Neonatorum: A Pilot Trial
Brief Summary: In this prospective trial the investigators plan to study the efficacy of erythropoietin as a therapeutic agent in neonates who suffer from brain injury following perinatal asphyxia.


Options:
A: Arm Label: infusions; Type: EXPERIMENTAL; Interventions: Biological: infusion of autologous cord blood | Arm Label: historical control; Type: OTHER; Interventions: Other: Neurodevelopmental outcomes | Intervention Type: BIOLOGICAL; Name: infusion of autologous cord blood; Assigned to Arm(s): infusions | Intervention Type: OTHER; Name: Neurodevelopmental outcomes; Assigned to Arm(s): historical control
B: Arm Label: EPO HIE Group; Type: EXPERIMENTAL; Interventions: Drug: Human recombinant erythropoietin, Procedure: EEG and Brain MRI, Biological: Nitric oxide measurement in the blood | Arm Label: Control HIE; Type: NO_INTERVENTION; Interventions: Procedure: EEG and Brain MRI, Biological: Nitric oxide measurement in the blood | Arm Label: Healthy Controls; Type: OTHER; Interventions: Biological: Nitric oxide measurement in the blood | Intervention Type: DRUG; Name: Human recombinant erythropoietin; Assigned to Arm(s): EPO HIE Group | Intervention Type: PROCEDURE; Name: EEG and Brain MRI; Assigned to Arm(s): Control HIE, EPO HIE Group | Intervention Type: BIOLOGICAL; Name: Nitric oxide measurement in the blood; Assigned to Arm(s): Control HIE, EPO HIE Group, Healthy Controls
C: Arm Label: PNEUMOSTEM®; Type: EXPERIMENTAL; Interventions: Biological: Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells | Intervention Type: BIOLOGICAL; Name: Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells; Assigned to Arm(s): PNEUMOSTEM®
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: erythropoietin | Intervention Type: DRUG; Name: erythropoietin; Assigned to Arm(s): A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of MEDI3414 in Adults
Brief Summary: The purpose of this study was to determine the safety and descriptive immunogenicity of the H1N1 influenza vaccine in healthy adults.


Options:
A: Intervention Type: BIOLOGICAL; Name: CAIV-T; Assigned to Arm(s): N/A
B: Arm Label: MEDI3414 [Influenza A (H1N1) vaccine]; Type: ACTIVE_COMPARATOR; Interventions: Biological: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal] | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal]; Assigned to Arm(s): MEDI3414 [Influenza A (H1N1) vaccine] | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: MEDI3414 [Influenza A (H1N1) vaccine]; Type: EXPERIMENTAL; Interventions: Biological: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal] | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal]; Assigned to Arm(s): MEDI3414 [Influenza A (H1N1) vaccine] | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: FluMist | Intervention Type: BIOLOGICAL; Name: FluMist; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of MEDI3414 in Adults
Brief Summary: The purpose of this study was to determine the safety and descriptive immunogenicity of the H1N1 influenza vaccine in healthy adults.


Options:
A: Arm Label: TIV; Type: ACTIVE_COMPARATOR; Interventions: Biological: Fluzone | Arm Label: LAIV; Type: ACTIVE_COMPARATOR; Interventions: Biological: Flumist | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Physiologic saline | Intervention Type: BIOLOGICAL; Name: Fluzone; Assigned to Arm(s): TIV | Intervention Type: BIOLOGICAL; Name: Flumist; Assigned to Arm(s): LAIV | Intervention Type: OTHER; Name: Physiologic saline; Assigned to Arm(s): Placebo
B: Arm Label: MEDI3414 [Influenza A (H1N1) vaccine]; Type: EXPERIMENTAL; Interventions: Biological: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal] | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal]; Assigned to Arm(s): MEDI3414 [Influenza A (H1N1) vaccine] | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: treatment; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Lactobacillus rhamnosus, Biological: Influenza Virus Vaccine Live, Intranasal | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: placebo control, Biological: Influenza Virus Vaccine Live, Intranasal | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus rhamnosus; Assigned to Arm(s): treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: placebo control; Assigned to Arm(s): placebo | Intervention Type: BIOLOGICAL; Name: Influenza Virus Vaccine Live, Intranasal; Assigned to Arm(s): placebo, treatment
D: Intervention Type: BIOLOGICAL; Name: Influenza virus vaccine (Fluviral); Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Saline placebo; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of MEDI3414 in Adults
Brief Summary: The purpose of this study was to determine the safety and descriptive immunogenicity of the H1N1 influenza vaccine in healthy adults.


Options:
A: Arm Label: Q/LAIV (MEDI3250); Type: EXPERIMENTAL; Interventions: Biological: Q/LAIV (MEDI3250) | Arm Label: FluMist/B/Yamagata; Type: ACTIVE_COMPARATOR; Interventions: Biological: FluMist/B/Yamagata | Arm Label: FluMist/B/Victoria; Type: ACTIVE_COMPARATOR; Interventions: Biological: FluMist/B/Victoria | Intervention Type: BIOLOGICAL; Name: Q/LAIV (MEDI3250); Assigned to Arm(s): Q/LAIV (MEDI3250) | Intervention Type: BIOLOGICAL; Name: FluMist/B/Yamagata; Assigned to Arm(s): FluMist/B/Yamagata | Intervention Type: BIOLOGICAL; Name: FluMist/B/Victoria; Assigned to Arm(s): FluMist/B/Victoria
B: Arm Label: Influenza; Type: EXPERIMENTAL; Interventions: Biological: Influenza vaccination | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Biological: Hepatitis A Vaccine | Intervention Type: BIOLOGICAL; Name: Influenza vaccination; Assigned to Arm(s): Influenza | Intervention Type: BIOLOGICAL; Name: Hepatitis A Vaccine; Assigned to Arm(s): Control
C: Arm Label: Vaccine; Type: EXPERIMENTAL; Interventions: Biological: SIIL Live Attenuated Influenza Vaccine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: SIIL Live Attenuated Influenza Vaccine; Assigned to Arm(s): Vaccine | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: MEDI3414 [Influenza A (H1N1) vaccine]; Type: EXPERIMENTAL; Interventions: Biological: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal] | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal]; Assigned to Arm(s): MEDI3414 [Influenza A (H1N1) vaccine] | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of Orientation and Mobility Training on Mobility, Participation and Quality of Life in Older Adults With Visual Impairments: a Randomised Controlled Trial
Brief Summary: The purpose of this study is:

1. to develop a standardised orientation and mobility training (O\&M-training) in the use of an identification/symbol cane by older adults with low vision, and;
2. to evaluate this newly developed standardised O\&M-training with respect to effectiveness and feasibility in a randomised controlled trial.


Options:
A: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: Overground visual cue training; Type: EXPERIMENTAL; Interventions: Behavioral: Overground visual cue training | Arm Label: Treadmill visual cue training; Type: EXPERIMENTAL; Interventions: Behavioral: Treadmill visual cue training | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care | Intervention Type: BEHAVIORAL; Name: Overground visual cue training; Assigned to Arm(s): Overground visual cue training | Intervention Type: BEHAVIORAL; Name: Treadmill visual cue training; Assigned to Arm(s): Treadmill visual cue training
B: Arm Label: BA-LVR; Type: EXPERIMENTAL; Interventions: Behavioral: BA-LVR | Arm Label: ST-LVR; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: ST-LVR | Intervention Type: BEHAVIORAL; Name: BA-LVR; Assigned to Arm(s): BA-LVR | Intervention Type: BEHAVIORAL; Name: ST-LVR; Assigned to Arm(s): ST-LVR
C: Arm Label: Yoga Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Yoga Intervention | Intervention Type: BEHAVIORAL; Name: Yoga Intervention; Assigned to Arm(s): Yoga Therapy
D: Arm Label: regular O&M-training; Type: ACTIVE_COMPARATOR; Interventions: Other: orientation and mobility training | Arm Label: standardised O&M-training; Type: EXPERIMENTAL; Interventions: Other: orientation and mobility training | Intervention Type: OTHER; Name: orientation and mobility training; Assigned to Arm(s): regular O&M-training, standardised O&M-training

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of Orientation and Mobility Training on Mobility, Participation and Quality of Life in Older Adults With Visual Impairments: a Randomised Controlled Trial
Brief Summary: The purpose of this study is:

1. to develop a standardised orientation and mobility training (O\&M-training) in the use of an identification/symbol cane by older adults with low vision, and;
2. to evaluate this newly developed standardised O\&M-training with respect to effectiveness and feasibility in a randomised controlled trial.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Problem Solving Treatment | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Problem Solving Treatment; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): 2
B: Arm Label: Ranibizumab 0.3 mg; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab | Arm Label: Ranibizumab 0.5 mg; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab | Arm Label: Sham injection/ranibizumab 0.5 mg; Type: SHAM_COMPARATOR; Interventions: Drug: Sham injection | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): Ranibizumab 0.3 mg, Ranibizumab 0.5 mg | Intervention Type: DRUG; Name: Sham injection; Assigned to Arm(s): Sham injection/ranibizumab 0.5 mg
C: Arm Label: Visual Reconstitution Therapy; Type: EXPERIMENTAL; Interventions: Other: Visual Reconstitutions Therapy | Arm Label: Saccadic Eye Movement Training; Type: ACTIVE_COMPARATOR; Interventions: Other: Saccadic Eye Movement Training | Intervention Type: OTHER; Name: Visual Reconstitutions Therapy; Assigned to Arm(s): Visual Reconstitution Therapy | Intervention Type: OTHER; Name: Saccadic Eye Movement Training; Assigned to Arm(s): Saccadic Eye Movement Training
D: Arm Label: regular O&M-training; Type: ACTIVE_COMPARATOR; Interventions: Other: orientation and mobility training | Arm Label: standardised O&M-training; Type: EXPERIMENTAL; Interventions: Other: orientation and mobility training | Intervention Type: OTHER; Name: orientation and mobility training; Assigned to Arm(s): regular O&M-training, standardised O&M-training

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of MEDI3414 in Children
Brief Summary: The purpose of this study was to determine the safety and descriptive immunogenicity of the H1N1 influenza vaccine in healthy children.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: FluMist | Intervention Type: BIOLOGICAL; Name: FluMist; Assigned to Arm(s): 1
B: Arm Label: MEDI3414 [Influenza A (H1N1) vaccine]; Type: EXPERIMENTAL; Interventions: Biological: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal] | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal]; Assigned to Arm(s): MEDI3414 [Influenza A (H1N1) vaccine] | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: MEDI3414 [Influenza A (H1N1) vaccine]; Type: ACTIVE_COMPARATOR; Interventions: Biological: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal] | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal]; Assigned to Arm(s): MEDI3414 [Influenza A (H1N1) vaccine] | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: BIOLOGICAL; Name: CAIV-T; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of MEDI3414 in Children
Brief Summary: The purpose of this study was to determine the safety and descriptive immunogenicity of the H1N1 influenza vaccine in healthy children.


Options:
A: Arm Label: MEDI3414 [Influenza A (H1N1) vaccine]; Type: ACTIVE_COMPARATOR; Interventions: Biological: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal] | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal]; Assigned to Arm(s): MEDI3414 [Influenza A (H1N1) vaccine] | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Total vaccinated cohort; Type: N/A; Interventions: Other: Safety follow up | Intervention Type: OTHER; Name: Safety follow up; Assigned to Arm(s): Total vaccinated cohort
C: Arm Label: MEDI3414 [Influenza A (H1N1) vaccine]; Type: EXPERIMENTAL; Interventions: Biological: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal] | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal]; Assigned to Arm(s): MEDI3414 [Influenza A (H1N1) vaccine] | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: CSL Limited Influenza Vaccine | Arm Label: 2; Type: OTHER; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: CSL Limited Influenza Vaccine; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of MEDI3414 in Children
Brief Summary: The purpose of this study was to determine the safety and descriptive immunogenicity of the H1N1 influenza vaccine in healthy children.


Options:
A: Arm Label: Vaccine; Type: EXPERIMENTAL; Interventions: Biological: SIIL Live Attenuated Influenza Vaccine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: SIIL Live Attenuated Influenza Vaccine; Assigned to Arm(s): Vaccine | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: MEDI3414 [Influenza A (H1N1) vaccine]; Type: EXPERIMENTAL; Interventions: Biological: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal] | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI3414 [Influenza A/H1N1 live attenuated, intranasal]; Assigned to Arm(s): MEDI3414 [Influenza A (H1N1) vaccine] | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: FluMist | Intervention Type: BIOLOGICAL; Name: FluMist; Assigned to Arm(s): 1
D: Arm Label: MEDI3414 [Influenza A (H1N1) vaccine]; Type: ACTIVE_COMPARATOR; Interventions: Biological: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal] | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal]; Assigned to Arm(s): MEDI3414 [Influenza A (H1N1) vaccine] | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: HF Assessment With BNP In The Home
Brief Summary: The HABIT clinical study is being performed to determine the benefit and optimal frequency for at home testing of B-type natriuretic peptide (BNP) for heart failure patients following hospitalization from decompensation. Subjects will be enrolled following hospitalization for decompensated heart failure. Enrolled subjects will be trained on the use of the Triage Touch meter for fingerstick BNP assessment; these subjects will then test their BNP levels daily using the Triage Touch product for approximately 60 days.


Options:
A: Arm Label: NT-proBNP guided treatment group; Type: ACTIVE_COMPARATOR; Interventions: Device: NT-proBNP measurements | Arm Label: Clinically guided arm; Type: PLACEBO_COMPARATOR; Interventions: Device: NT-proBNP measurements | Intervention Type: DEVICE; Name: NT-proBNP measurements; Assigned to Arm(s): Clinically guided arm, NT-proBNP guided treatment group
B: Arm Label: Heart Failure; Type: N/A; Interventions: N/A
C: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: OTHER; Interventions: Other: Intervention Care | Intervention Type: OTHER; Name: Intervention Care; Assigned to Arm(s): Intervention
D: Intervention Type: PROCEDURE; Name: BNP-guided care in addition to multidisciplinary management; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double-blind, Double-dummy, Randomised, Multicentre, Comparative Study on the Efficacy and Safety of Azathioprine Versus Mesalazine for Prevention of Clinical Relapses in Crohn's Disease Patients With Postoperative Moderate or Severe Endoscopic Recurrence
Brief Summary: This study aims to compare azathioprine versus mesalazine tablets for the prevention of clinical relapse in postoperative Crohn's disease (CD) patients with moderate or severe endoscopic recurrence.


Options:
A: Arm Label: Azathioprine; Type: EXPERIMENTAL; Interventions: Drug: Azathioprine, Drug: Mesalazine placebo | Arm Label: Mesalazine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mesalazine, Drug: Azathioprine placebo | Intervention Type: DRUG; Name: Azathioprine; Assigned to Arm(s): Azathioprine | Intervention Type: DRUG; Name: Mesalazine; Assigned to Arm(s): Mesalazine | Intervention Type: DRUG; Name: Azathioprine placebo; Assigned to Arm(s): Mesalazine | Intervention Type: DRUG; Name: Mesalazine placebo; Assigned to Arm(s): Azathioprine
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: infliximab+azathioprine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: methylprednisolone or budesonide | Intervention Type: DRUG; Name: infliximab+azathioprine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: methylprednisolone or budesonide; Assigned to Arm(s): 2
C: Arm Label: control = conventional treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Immunossuppresive treatment; Type: EXPERIMENTAL; Interventions: Drug: early immunosuppressants (azathioprine, methotrexate) | Intervention Type: DRUG; Name: early immunosuppressants (azathioprine, methotrexate); Assigned to Arm(s): Immunossuppresive treatment
D: Arm Label: 003; Type: EXPERIMENTAL; Interventions: Other: infliximab (IFX) infusion; azathioprine (AZA) caps | Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: infliximab (IFX) placebo infusion; azathioprine (AZA) caps | Arm Label: 002; Type: EXPERIMENTAL; Interventions: Biological: infliximab infusion; AZA placebo caps | Intervention Type: BIOLOGICAL; Name: infliximab infusion; AZA placebo caps; Assigned to Arm(s): 002 | Intervention Type: OTHER; Name: infliximab (IFX) infusion; azathioprine (AZA) caps; Assigned to Arm(s): 003 | Intervention Type: DRUG; Name: infliximab (IFX) placebo infusion; azathioprine (AZA) caps; Assigned to Arm(s): 001

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double-blind, Double-dummy, Randomised, Multicentre, Comparative Study on the Efficacy and Safety of Azathioprine Versus Mesalazine for Prevention of Clinical Relapses in Crohn's Disease Patients With Postoperative Moderate or Severe Endoscopic Recurrence
Brief Summary: This study aims to compare azathioprine versus mesalazine tablets for the prevention of clinical relapse in postoperative Crohn's disease (CD) patients with moderate or severe endoscopic recurrence.


Options:
A: Arm Label: Systematic azathioprine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azathioprine, Procedure: Ileocolonoscopy, Procedure: Small bowel follow trough | Arm Label: Endoscopy-driven azathioprine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azathioprine in case of endoscopic recurrence, Procedure: Ileocolonoscopy, Procedure: Small bowel follow trough | Intervention Type: DRUG; Name: Azathioprine; Assigned to Arm(s): Systematic azathioprine group | Intervention Type: DRUG; Name: Azathioprine in case of endoscopic recurrence; Assigned to Arm(s): Endoscopy-driven azathioprine group | Intervention Type: PROCEDURE; Name: Ileocolonoscopy; Assigned to Arm(s): Endoscopy-driven azathioprine group, Systematic azathioprine group | Intervention Type: PROCEDURE; Name: Small bowel follow trough; Assigned to Arm(s): Endoscopy-driven azathioprine group, Systematic azathioprine group
B: Arm Label: Active arm; Type: ACTIVE_COMPARATOR; Interventions: Procedure: endoscopy | Arm Label: Standard care arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: endoscopy; Assigned to Arm(s): Active arm
C: Arm Label: Azathioprine; Type: EXPERIMENTAL; Interventions: Drug: Azathioprine, Drug: Mesalazine placebo | Arm Label: Mesalazine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mesalazine, Drug: Azathioprine placebo | Intervention Type: DRUG; Name: Azathioprine; Assigned to Arm(s): Azathioprine | Intervention Type: DRUG; Name: Mesalazine; Assigned to Arm(s): Mesalazine | Intervention Type: DRUG; Name: Azathioprine placebo; Assigned to Arm(s): Mesalazine | Intervention Type: DRUG; Name: Mesalazine placebo; Assigned to Arm(s): Azathioprine
D: Intervention Type: DRUG; Name: Probiotic - VSL#3; Assigned to Arm(s): N/A

Answer: C